Search
Repligen Corp
RGENAdd to Watchlist
173.490USD
+5.010+2.97%
Close 11-06 16:00（ET）
11.09BMarket Cap
190.08P/E TTM
Today
+2.97%
5 Days
-1.95%
1 Month
-0.78%
6 Months
+37.95%
Year to Date
+5.88%
1 Year
+19.66%
Key Figures
169.350Open
175.000High
61.43KVolume
190.08P/E TTM
68.03P/E Dynamic
--Dividend TTM
0.10%Turnover Ratio
168.480Prev. Close
168.050Low
10.59MTurnover
LossP/E Static
5.31P/B
0.00%Div Yield TTM
1.78%ROA
198.87052wk High
0.03Volume Ratio
-25.51MNet Profit
63.92MShares
0.9135EPS TTM
1.09Beta
2.51%ROE
100.99052wk Low
5.12%Amplitude
54.19%Gross Margin
11.09BMarket Cap
5.37Reward/Risk
2.94%Risk Rate
Repligen Corp's Score
0.05vs previous score
Forecast8.10
Financial Health7.37
Technical3.50
Valuation Dimensions9.42
Institutional Confidence10.00
Risk Assessment5.63
Media Coverage
Coverage Level
Very Low
Very High
No data
Analyst Rating
Repligen Corp Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Sell
Repligen Corp Latest Earnings Call Transcripts
Repligen (RGEN) Q3 2026 Earnings Call: Record Revenue and Raised Guidance
Repligen's Q3 2026 earnings call covered record $209 million revenue, 12.5% organic growth, BioLife integration and higher full-year guidance.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.68/0.46
Revenue / Forecast
209.31M/206.62M
Repligen Corp Profile
SectorHealthcare Equipment & Supplies
Ticker SymbolRGEN
Number of employees1778
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 8.31% |
| T. Rowe Price Associates, Inc. | 8.06% |
| United Capital Financial Advisors, LLC | 4.91% |
| Roy T. Eddleman UEO | 4.85% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 62.92% |
| Investment Advisor/Hedge Fund | 38.33% |
| Hedge Fund | 9.18% |
| Individual Investor | 5.23% |
Related Instruments
-0.40%
+2.63%
-3.23%
+1.73%
-3.36%
-2.90%
-2.75%
+3.10%
-2.46%
-1.48%
-2.62%
-1.80%
-4.23%
+1.31%
-0.78%
+0.79%
-0.30%
+5.33%
+1.73%
-2.05%Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of Repligen Corp (RGEN)?
The current price of Repligen Corp (RGEN) is 173.49.
What is the symbol of Repligen Corp?
The ticker symbol of Repligen Corp is RGEN.
What is the 52-week high of Repligen Corp?
The 52-week high of Repligen Corp is 198.87.
What is the 52-week low of Repligen Corp?
The 52-week low of Repligen Corp is 100.99.
What is the market capitalization of Repligen Corp?
The market capitalization of Repligen Corp is 11.09B.
Is Repligen Corp (RGEN) currently rated as Buy, Hold, or Sell?
According to analysts, Repligen Corp (RGEN) has an overall rating of Buy, with a price target of 205.63.
What is the Earnings Per Share (EPS TTM) of Repligen Corp (RGEN)?
The Earnings Per Share (EPS TTM) of Repligen Corp (RGEN) is 0.91.